Analysis of a serie of 55 patients with biopsy proven giant cell temporal arteritis;Análisis de una serie de 55 pacientes con arteritis de células gigantes confirmada por biopsia

Anales de Medicina Interna

Volumn 21, Issue 10, 2004, Pages 473-476

  Bustamante Maldonado, E ^a   Mari Alfonso B ^a   Monteagudo Jiménez, Manuel ^a,b   Casanovas Martinez A ^a   Jordana Comajuncosa, R ^a   Tolosa Vilella, C ^a   Oristrell Salva J ^a  

^a Servicio de Oncología Médica   (Spain)

^b HOSPITAL DE SABADELL   (Spain)

Author keywords

Giant cell arteritis; Horton disease; Temporal arteritis; Temporal artery biopsy; Vasculitis

Indexed keywords

PREDNISONE;

ADULT; AGED; AMYLOIDOSIS; ANEMIA; ARTICLE; ASEPTIC NECROSIS; BLOOD VESSEL BIOPSY; CATARACT; CLAUDICATION; CLINICAL FEATURE; DIABETES MELLITUS; DIGESTIVE SYSTEM HEMORRHAGE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GIANT CELL ARTERITIS; HEADACHE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; RETROSPECTIVE STUDY; SYMPTOMATOLOGY; TEMPORAL ARTERITIS; THROMBOCYTOSIS; VISUAL IMPAIRMENT;

BIOPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TEMPORAL ARTERIES; TEMPORAL ARTERITIS;

EID: 8844266901     PISSN: 02127199     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Evans JM, Hunder GG. Polymyalgia rheumatica and giant cell arteritis. Clin in Geriatr Med 1998; 14: 455-73.
2. Calvo Romero JM. Arteritis de células gigantes. An Med Interna (Madrid) 2002; 19: 257-262.
3. Levine SM, Hellmann DB. Giant cell arteritis. Curr Opin Rheumatol 2002; 14: 3-10.
4. González-Gay MA, Blanco R, Sánchez-Andrade A, Vázquez-Caruncho M. Giant cell arteritis in Lugo, Spain: A more frecuent disease with fewer classic features. J Rheumatol 1997; 24: 2166-80.
5. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH et al. The American College of Rheumatology 1990 criteria for the clasification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122-1128.
6. Lie JT, Members and Consultants of the American College of Rheumatology Subcommittee on Classification of Vasculitis: Illustrated histopathology classification criteria for selectec vasculitis syndrome. Arthritis Rheum 1990; 33: 1074-87.
7. Salvarani C, Macchioni P, Zizzi F, Mantovani W, Rossi F, Castri C, et al. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy (see comments) Arthritis Rheum 1991; 34: 351-6
8. Sonnenblick M, Nesher G, Friedlander Y, Rubinow A. Giant cell arteritis in Jerusalem: a 12-year epidemiological study. Br J Rheumatol 1994; 33: 998-41.
9. Smith CA, Fidler WJ, Pinals RS. The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee. Arthritis Rheum 1983; 26: 1214-9
10. Elling P, Olsson AT, Elling H. Synchronous variations of incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of mycoplasma pneumoniae infection. J Rheumatol 1996; 23: 112-19.
11. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. The incidence of giant cell arteritis in Olmsted County, Minnesota: Apparent fluctuations in a cyclic pattern. Ann Intern Med 1995; 123: 192-194.
12. V. Petursdottir, H. Johansson, E. Nordborg, C. Nordborg. The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations. Rheumatology 1999; 38: 1208-1212.
13. Machado EBV, Michet CJ, Ballard DJ, Hunder CG, Beard CM, ChuPin Ch et al. Trends in incidence and clinical presentation of temporal arteritis in Olmsted county, Minnesota, 1950-1985. Arthritis Rheum 1988; 31: 745-749.
14. Baldursson O, Steinsson K, Bjornsson J, Lie JT. Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis. Arthritis Rheum 1994; 37: 1007-1012.
15. Calvo JM, Magro D, Ramos JL, et al. Arteritis de células gigantes: un estudio descriptivo en el suroeste de España. An Med Interna (Madrid) 2000; 17: 67-70
16. Armona J, Rodríguez-Valverde V, González-Gay MA, Figueroa M, Fernández-Sueiro JL, Blanco R, Martínez-Taboada V. Arteritis de células gigantes. Estudio de 191 pacientes. Med Clin (Bare) 1995; 105: 734-737.
17. Vilalta J, Vilaseca J, Ingelmo M, González L, Tor J, Coca A, Bacardi R, Balcells-Gorina A. Arteritis Temporal. Estudio de 43 casos. Med Clin (Barc) 1982; 78: 307-312.
18. Rivero Puente A, Berasategui Calderón JL, Murie Carrillo de Albornoz JM, Rivero Marcotegui M, García-Bragado Acín F. Arteritis de células gigantes y polimialgia reúmática: diagnóstico y evolución de 90 casos. An Med Interna (Madrid) 2001; 18: 191-194
19. Liu GT, Glaser JS, Schatz NJ, Smith JL. Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis vision. Ophthalmology 1994; 101: 1779-1785
20. Cid M, Font C, Oristrell J, De la Sierra A, Coll-Vinent B, López-Soto A. Vilaseca J, Urbano-Márquez A, Grau JM. Association between strong inflammatory response and low risk of developing visual loss and other cranial isquemic complications in giant cell (temporal) arteritis. Arthritis Rheum 1998; 41: 26-32.
21. González-Gay M, Banco R, Rodríguez- Valverde V, Martínez-Taboada V, Delgado-Rodríguez M, Figueroa M, Uriarte E. Permanent visual loss and cerebrovascular accidents in giant cell arteritis. Arthritis Rheum 1998; 41: 1497-1504.
22. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell artertis. N Engl J Med 2002; 347: 261-271
23. Liozon E, Herrmann F, Ly K, Robert PY, Loustaud V, Soria P, Vidal E. Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. Am J Med 2001; 111: 211-7
24. Recommendations for the prevention and treatment of glucocorticoid- induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocoritcoid-Induced Osteoporosis. Arthritis Rheum 2001; 44: 1496-503.
25. Adachi JD, Saag KG, Delmas PD, et al. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2001; 44: 202-1126.